They have approval for immediate start in those countries , is that a regulatory tick or IRB? I assume the latter otherwise they couldn’t start but then trial isn’t posted to clinical trials.gov where these things really should be available. I’m keen to look at the design in detail.
- Forums
- ASX - By Stock
- NOX
- Ann: Veyonda COVID-19 Study Approved For Immediate Start
Ann: Veyonda COVID-19 Study Approved For Immediate Start, page-7
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.04M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 67034 | 7.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.9¢ | 21222 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 67034 | 0.072 |
1 | 10559 | 0.069 |
2 | 14000 | 0.068 |
2 | 76672 | 0.066 |
1 | 15000 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 21222 | 2 |
0.080 | 112099 | 3 |
0.081 | 22345 | 2 |
0.086 | 100000 | 1 |
0.090 | 51000 | 2 |
Last trade - 16.12pm 19/07/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
Day chart unavailable